Total Payments
$22,692
2024 Payments
$737.24
Companies
34
Transactions
350
Medicare Patients
7,754
Medicare Billing
$882,981
Payment Breakdown by Category
Other$10,350 (45.6%)
Food & Beverage$8,302 (36.6%)
Consulting$2,634 (11.6%)
Travel$1,380 (6.1%)
Education$26.05 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,750 | 7 | 38.6% |
| Food and Beverage | $8,302 | 329 | 36.6% |
| Consulting Fee | $2,634 | 5 | 11.6% |
| Honoraria | $1,600 | 1 | 7.1% |
| Travel and Lodging | $1,380 | 3 | 6.1% |
| Education | $26.05 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $5,998 | 48 | $0 (2019) |
| Dexcom, Inc. | $3,830 | 18 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $3,333 | 19 | $0 (2020) |
| Novo Nordisk Inc | $2,409 | 24 | $0 (2023) |
| Lilly USA, LLC | $1,324 | 25 | $0 (2022) |
| Amgen Inc. | $810.94 | 42 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $640.11 | 7 | $0 (2019) |
| Insulet Corporation | $573.58 | 26 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $501.48 | 23 | $0 (2023) |
| Shire North American Group Inc | $330.14 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $737.24 | 14 | Insulet Corporation ($332.20) |
| 2023 | $2,388 | 10 | Novo Nordisk Inc ($1,740) |
| 2022 | $442.56 | 8 | Esperion Therapeutics, Inc. ($124.97) |
| 2020 | $191.40 | 5 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2019 | $1,792 | 78 | Novo Nordisk Inc ($244.32) |
| 2018 | $8,505 | 112 | Boehringer Ingelheim Pharmaceuticals, Inc. ($5,706) |
| 2017 | $8,637 | 123 | Dexcom, Inc. ($3,562) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $115.49 | General |
| Category: Insulin Pump | ||||||
| 12/05/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $111.30 | General |
| Category: Insulin Pump | ||||||
| 11/27/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $21.87 | General |
| Category: Insulin Pump | ||||||
| 11/20/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.65 | General |
| 08/21/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $23.67 | General |
| Category: Insulin Pump | ||||||
| 07/31/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.61 | General |
| Category: Insulin Pump | ||||||
| 07/10/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $113.98 | General |
| Category: Automated insulin delivery system | ||||||
| 06/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 05/31/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.08 | General |
| Category: Insulin Pump | ||||||
| 05/22/2024 | Medtronic, Inc. | AZURE XT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $82.20 | General |
| Category: Pacemakers | ||||||
| 04/20/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Cardiology | ||||||
| 01/31/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $11.18 | General |
| Category: Insulin Pump | ||||||
| 01/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardiology | ||||||
| 12/22/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/06/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $870.00 | General |
| 12/05/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $870.00 | General |
| 11/28/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $105.74 | General |
| Category: Durable Pump | ||||||
| 09/28/2023 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Genetic Disease | ||||||
| 07/01/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $119.03 | General |
| Category: Endocrinology | ||||||
| 05/31/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Endocrinology | ||||||
| 05/25/2023 | Amryt Pharma Holdings Ltd | MYCAPSSA (Drug) | Food and Beverage | In-kind items and services | $139.08 | General |
| Category: Endocrinology | ||||||
| 03/24/2023 | Kiniksa Pharmaceuticals, Ltd. | — | Food and Beverage | Cash or cash equivalent | $112.99 | General |
| 02/14/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/14/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,816 | 10,544 | $795,036 | $309,871 |
| 2022 | 10 | 1,839 | 4,051 | $472,108 | $186,427 |
| 2021 | 12 | 1,954 | 4,369 | $492,319 | $204,277 |
| 2020 | 18 | 2,145 | 4,172 | $515,161 | $182,406 |
Total Patients
7,754
Total Services
23,136
Medicare Billing
$882,981
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 80 | 7,860 | $337,980 | $143,667 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 945 | 1,411 | $318,561 | $114,809 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 168 | 168 | $51,024 | $18,451 | 36.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 218 | $29,866 | $12,927 | 43.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 67 | $17,353 | $6,581 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 92 | $13,503 | $5,136 | 38.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 95 | 167 | $11,860 | $4,222 | 35.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 95 | 334 | $13,073 | $3,375 | 25.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 222 | 227 | $1,816 | $703.65 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 993 | 1,506 | $310,594 | $124,296 | 40.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 12 | 1,140 | $43,140 | $19,377 | 44.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 123 | 123 | $37,198 | $13,394 | 36.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 72 | 216 | $29,840 | $11,365 | 38.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 65 | 69 | $18,003 | $6,879 | 38.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 87 | 142 | $10,291 | $3,652 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 54 | $7,722 | $2,750 | 35.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 26 | 198 | $7,671 | $1,786 | 23.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 390 | 555 | $4,049 | $1,771 | 43.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 21 | 48 | $3,600 | $1,156 | 32.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 1,046 | 1,590 | $315,392 | $133,185 | 42.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 14 | 1,441 | $51,876 | $23,042 | 44.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 146 | 146 | $44,285 | $17,264 | 39.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 82 | 205 | $28,463 | $11,262 | 39.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 73 | 75 | $19,690 | $7,743 | 39.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 72 | 77 | $10,333 | $4,339 | 42.0% |
About Dr. Vasdev Lohano, MD
Dr. Vasdev Lohano, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Washington, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316906738.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vasdev Lohano, MD has received a total of $22,692 in payments from pharmaceutical and medical device companies, with $737.24 received in 2024. These payments were reported across 350 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,750).
As a Medicare-enrolled provider, Lohano has provided services to 7,754 Medicare beneficiaries, totaling 23,136 services with total Medicare billing of $882,981. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Washington, IN
- Active Since 03/23/2006
- Last Updated 05/24/2023
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1316906738
Products in Payments
- JARDIANCE (Drug) $6,885
- Dexcom G5 Mobile CGM System (Device) $3,562
- FARXIGA (Drug) $3,264
- t-slim insulin pump (Device) $640.11
- Omnipod (Device) $573.58
- Repatha (Biological) $421.44
- Prolia (Biological) $279.24
- Ozempic (Drug) $277.16
- INVOKANA (Drug) $268.45
- TRADJENTA (Drug) $260.32
- Minimed 670G System (Device) $249.77
- JANUVIA (Drug) $242.61
- Korlym (Drug) $226.73
- SOLIQUA (Drug) $217.78
- NATPARA (Drug) $171.28
- ZONTIVITY (Drug) $149.70
- MYCAPSSA (Drug) $139.08
- PRALUENT (Drug) $136.57
- Kerendia (Drug) $125.00
- FABRAZYME (Biological) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Washington
Natasa Janicic-Kahric
Endocrinology, Diabetes & Metabolism — Payments: $343,214
Endocrinology, Diabetes & Metabolism $343,214
Robert Ratner, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $90,184
Endocrinology, Diabetes & Metabolism $90,184
Adline Ghazi, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $67,397
Endocrinology, Diabetes & Metabolism $67,397
Leonard Wartofsky, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $66,424
Endocrinology, Diabetes & Metabolism $66,424
Meeta Sharma, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $61,957
Endocrinology, Diabetes & Metabolism $61,957
Joseph Verbalis
Endocrinology, Diabetes & Metabolism — Payments: $44,007
Endocrinology, Diabetes & Metabolism $44,007